DST FOUNDATION IS A NON-PROFIT, CHARITABLE ORGANIZATION THAT PROMOTES SCIENTIFIC INNOVATIONS TO THE INTERNATIONAL MARKET.

Our projects are the novice, patented medicines and medical technologies at the stage of trials. Each of the products and technologies - is a break-through in its field. They open new possibilities in diagnostics, prevention or treatment of various illnesses.

The essence of the “Emission” project is the possibility to transmit emission (properties) of organic and inorganic substances and biological objects remotely via communication lines using Internet addressing system.

Authors of the invention: Ph.D. Biology, Candidate of Chemical Sciences, Kuznetsova Irina and Ph.D. Medicine Evgeny Maevsky. AT300 was developed on the basis of the Russian Scientific-Research Institute of Hematology and Transfusion Medicine, St. Petersburg.

Dissymetric therapy (anisotropizing) tinctorial therapy (DST) – is an innovative method of oncological diseases treatment. It is based on the theory of Professor Kutushov about the causes of cancer and it's development.

Scientific American placed Professor Eshel Ben-Jacob and Dr. Itay Baruchi's creation of a type of organic memory chip on its list of the year's 50 most significant scientific discoveries in 2007. For the last decade, he has pioneered the field of Systems Neuroscience, focusing first on investigations of living neural networks outside the brain.

Watch his video lecture: "Learning from bacteria about social networks" that he gave for Google Tech Talks on September 30th 2011.

In this section you will find photo, video and audio materials from the past conferences of DST Fund, as well as photos from the meetings and negotiation in Russia and abroad in which DST Fund representatives have taken part.